Year |
Citation |
Score |
2023 |
Konopleva M, DiNardo C, Bhagat T, Baran N, Lodi A, Saxena K, Cai T, Su X, Skwarska A, Guerra V, Kuruvilla V, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, ... ... Tiziani S, et al. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Research Square. PMID 36865338 DOI: 10.21203/rs.3.rs-2518774/v1 |
0.639 |
|
2023 |
Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F, Collins ME, Francesco MED, Dumbrava EE, Fu S, Gao S, Gay JP, Gera S, ... ... Tiziani S, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature Medicine. PMID 36658425 DOI: 10.1038/s41591-022-02103-8 |
0.622 |
|
2022 |
Hua X, Li Y, Pentaparthi SR, McGrail DJ, Zou R, Guo L, Shrawat A, Cirillo KM, Li Q, Bhat AV, Xu M, Qi D, Singh A, McGrath F, Andrews SB, ... ... Tiziani S, et al. Landscape of microRNA regulatory network architecture and functional rerouting in cancer. Cancer Research. PMID 36265133 DOI: 10.1158/0008-5472.CAN-20-0371 |
0.576 |
|
2022 |
Lodi A, Pandey R, Chiou J, Bhattacharya A, Huang S, Pan X, Burgman B, Yi SS, Tiziani S, Brenner AJ. Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide. Frontiers in Oncology. 12: 900082. PMID 36226069 DOI: 10.3389/fonc.2022.900082 |
0.643 |
|
2022 |
Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Tremblay M, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, ... ... Tiziani S, et al. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nature Communications. 13: 2801. PMID 35589701 DOI: 10.1038/s41467-022-30396-3 |
0.663 |
|
2022 |
Lu X, Hackman GL, Saha A, Rathore AS, Collins M, Friedman C, Yi SS, Matsuda F, DiGiovanni J, Lodi A, Tiziani S. Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry. Iscience. 25: 104221. PMID 35494234 DOI: 10.1016/j.isci.2022.104221 |
0.596 |
|
2022 |
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, ... ... Tiziani S, et al. Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduction and Targeted Therapy. 7: 110. PMID 35365596 DOI: 10.1038/s41392-022-00958-4 |
0.608 |
|
2022 |
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, ... ... Tiziani S, et al. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduction and Targeted Therapy. 7: 51. PMID 35185150 DOI: 10.1038/s41392-021-00870-3 |
0.637 |
|
2021 |
Gries P, Rathore AS, Lu X, Chiou J, Huynh YB, Lodi A, Tiziani S. Automated Trimethyl Sulfonium Hydroxide Derivatization Method for High-Throughput Fatty Acid Profiling by Gas Chromatography-Mass Spectrometry. Molecules (Basel, Switzerland). 26. PMID 34684827 DOI: 10.3390/molecules26206246 |
0.582 |
|
2021 |
Zavorka Thomas ME, Lu X, Talebi Z, Jeon JY, Buelow DR, Gibson AA, Uddin ME, Brinton LT, Nguyen J, Collins M, Lodi A, Sweeney SR, Campbell MJ, Sweet DH, Sparreboom A, ... ... Tiziani S, et al. Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-positive AML. Molecular Cancer Therapeutics. PMID 34518298 DOI: 10.1158/1535-7163.MCT-21-0071 |
0.674 |
|
2021 |
Lu X, Han L, Busquets J, Collins M, Lodi A, Marszalek JR, Konopleva M, Tiziani S. The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells. Frontiers in Oncology. 11: 686765. PMID 34490088 DOI: 10.3389/fonc.2021.686765 |
0.664 |
|
2021 |
Pandey R, Collins M, Lu X, Sweeney SR, Chiou J, Lodi A, Tiziani S. Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry. Analytical Chemistry. PMID 33818082 DOI: 10.1021/acs.analchem.0c05325 |
0.621 |
|
2021 |
Stanford SM, Collins M, Diaz MA, Holmes ZJ, Gries P, Bliss MR, Lodi A, Zhang V, Tiziani S, Bottini N. The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy. Journal of Cellular Physiology. PMID 33615467 DOI: 10.1002/jcp.30307 |
0.609 |
|
2020 |
Hackman GL, Collins M, Lu X, Lodi A, DiGiovanni J, Tiziani S. Predicting and Quantifying Antagonistic Effects of Natural Compounds Given with Chemotherapeutic Agents: Applications for High-Throughput Screening. Cancers. 12. PMID 33322034 DOI: 10.3390/cancers12123714 |
0.614 |
|
2020 |
Choudhury FK, Hackman GL, Lodi A, Tiziani S. Stable Isotope Tracing Metabolomics to Investigate the Metabolic Activity of Bioactive Compounds for Cancer Prevention and Treatment. Cancers. 12. PMID 32756373 DOI: 10.3390/Cancers12082147 |
0.685 |
|
2020 |
Lu WC, Saha A, Yan W, Garrison K, Lamb C, Pandey R, Irani S, Lodi A, Lu X, Tiziani S, Zhang YJ, Georgiou G, DiGiovanni J, Stone E. Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity. Proceedings of the National Academy of Sciences of the United States of America. PMID 32434918 DOI: 10.1073/Pnas.1917362117 |
0.635 |
|
2020 |
Sweeney SR, Collins M, Pandey R, Chiou J, Lodi A, Tiziani S. Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia. Molecular Carcinogenesis. PMID 32027051 DOI: 10.1002/Mc.23163 |
0.713 |
|
2020 |
Thomas MZ, Jeon JY, Shabana S, Buelow D, Gibson A, Anderson J, Campbell M, Collins M, Lodi A, Sweeney S, Tiziani S, Sparreboom A, Baker S. Gilteritinib Inhibits Acute Myeloid Leukemia Growth via Reduction in Glutamine Uptake and Utilization The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04281 |
0.628 |
|
2019 |
Lu X, Lodi A, Konopleva M, Tiziani S. Three-Dimensional Leukemia Co-Culture System for In Vitro High-Content Metabolomics Screening. Slas Discovery : Advancing Life Sciences R & D. 2472555219860446. PMID 31345091 DOI: 10.1177/2472555219860446 |
0.64 |
|
2019 |
Sanchez-Lopez E, Zhong Z, Stubelius A, Sweeney SR, Booshehri LM, Antonucci L, Liu-Bryan R, Lodi A, Terkeltaub R, Lacal JC, Murphy AN, Hoffman HM, Tiziani S, Guma M, Karin M. Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production. Cell Metabolism. PMID 30982734 DOI: 10.1016/J.Cmet.2019.03.011 |
0.63 |
|
2019 |
Baran N, Lodi A, Sweeney SR, Kuruvilla VM, Cavazos A, Herranz D, Skwarska A, Warmoes M, Davis E, Harutyunyan K, Feng N, Gay JP, Kaminski M, Konoplev S, Jabbour E, ... ... Tiziani S, et al. Glutaminase Inhibition Overcomes Acquired Resistance to Mitochondrial Complex I in NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemias (T-ALL) Via Block of Glutamine Driven Reductive Metabolism Blood. 134: 806-806. DOI: 10.1182/Blood-2019-128930 |
0.685 |
|
2019 |
Zhang Q, Lodi A, Sweeney SR, Han L, Cai T, Kuruvilla VM, Cavazos A, Ma H, Tabe Y, Marszalek JR, Tiziani S, Konopleva MY. Inhibiting Mitochondria Function By Bcl-2 Inhibitor Venetoclax and Complex I Inhibitor Iacs-010759 Eliminate Leukemia Cells in Pre-Clinical AML Models Blood. 134: 3927-3927. DOI: 10.1182/Blood-2019-124494 |
0.683 |
|
2019 |
Gruslova A, Lodi A, Li M, Zhou M, Garcia M, Tiziani S, Brenner A, Caflisch L. CBMT-39. TARGETING METABOLIC PATHWAYS IN HYPOXIA FOR GLIOBLASTOMA Neuro-Oncology. 21: vi41-vi41. DOI: 10.1093/Neuonc/Noz175.161 |
0.696 |
|
2018 |
Narasimhan R, Coras R, Rosenthal SB, Sweeney SR, Lodi A, Tiziani S, Boyle D, Kavanaugh A, Guma M. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Research & Therapy. 20: 164. PMID 30075744 DOI: 10.1186/S13075-018-1655-3 |
0.635 |
|
2018 |
Triplett TA, Garrison KC, Marshall N, Donkor M, Blazeck J, Lamb C, Qerqez A, Dekker JD, Tanno Y, Lu WC, Karamitros CS, Ford K, Tan B, Zhang XM, McGovern K, ... ... Tiziani S, et al. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. Nature Biotechnology. PMID 30010674 DOI: 10.1038/Nbt.4180 |
0.326 |
|
2018 |
Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, ... ... Tiziani S, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nature Medicine. PMID 29892070 DOI: 10.1038/S41591-018-0052-4 |
0.683 |
|
2018 |
Falconer J, Murphy AN, Young S, Clark AR, Tiziani S, Guma M, Buckley CD. Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29579371 DOI: 10.1002/Art.40504 |
0.372 |
|
2018 |
Bryant JD, Sweeney SR, Sentandreu E, Shin M, Ipas H, Xhemalce B, Momb J, Tiziani S, Appling DR. Deletion of the neural tube defect-associated genedisrupts one-carbon and central energy metabolism in mouse embryos. The Journal of Biological Chemistry. PMID 29483189 DOI: 10.1074/Jbc.Ra118.002180 |
0.362 |
|
2018 |
Brenner A, Zuniga R, Sun JD, Floyd J, Hart CP, Kroll S, Fichtel L, Cavazos D, Caflisch L, Gruslova A, Lodi A, Tiziani S. Hypoxia Activated Evofosfamide for Treatment of Recurrent Bevacizumab-Refractory Glioblastoma: A phase I surgical study. Neuro-Oncology. PMID 29415215 DOI: 10.1093/Neuonc/Noy015 |
0.631 |
|
2018 |
Baran N, Lodi A, Sweeney SR, Renu P, Kuruvilla VM, Cavazos A, Herranz D, Skwarska A, Warmoes M, Davis RE, Harutyunyan K, Feng N, Gay JP, Konoplev SN, Kaminski M, ... ... Tiziani S, et al. Mitochondrial Complex I Inhibitor Iacs-010759 Reverses the NOTCH1-Driven Metabolic Reprogramming in T-ALL Via Blockade of Oxidative Phosphorylation: Synergy with Chemotherapy and Glutaminase Inhibition Blood. 132: 4020-4020. DOI: 10.1182/Blood-2018-99-117310 |
0.695 |
|
2018 |
Konopleva MY, Lorenzi PL, Ghotbaldini S, Tabe Y, Cai T, Tiziani S. Contribution of Amino Acid Metabolism to Hematologic Malignancies Blood. 132: SCI-10-SCI-10. DOI: 10.1182/Blood-2018-99-109469 |
0.449 |
|
2018 |
Winikka L, Quach D, Harlow B, Brenner A, Munoz N, Tiziani S, deGraffenried L. Abstract P1-03-12: The ratio of omega-3 to omega-6 PUFAs impact cancer cell phenotype in the tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-03-12 |
0.351 |
|
2018 |
Kshattry S, Georgiou G, Tiziani S, Saha A, Stone E, DiGiovanni J. Abstract 3963: Cystine depleting human enzyme combined with auranofin synergistically inhibits pancreatic cancer cell growth in vitro and in vivo Cancer Research. 78: 3963-3963. DOI: 10.1158/1538-7445.Am2018-3963 |
0.383 |
|
2018 |
Baran N, Lodi A, Sweeney S, Kuruvilla VM, Cavazos A, Skwarska A, Velandy SS, Harutyunyan K, Feng N, Kaminski M, Jabbour EJ, Ferrando A, Francesco MED, Marszalek JR, Tiziani S, et al. Abstract 1875: Oxidative metabolism as a novel therapeutic target to eradicate T-ALL with mitochondrial complex I inhibitor IACS-010759 Cancer Research. 78: 1875-1875. DOI: 10.1158/1538-7445.Am2018-1875 |
0.696 |
|
2018 |
Caflisch L, Gruslova A, Garcia M, Lodi A, Tiziani S, Brenner AJ. Cbmt-11. Peroxisomal Fatty Acid Oxidation In Glioblastoma During Hypoxia Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.130 |
0.603 |
|
2017 |
Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. Npj Precision Oncology. 1: 30. PMID 29873330 DOI: 10.1038/s41698-017-0027-9 |
0.617 |
|
2017 |
Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. Npj Precision Oncology. 1. PMID 29202102 DOI: 10.1038/s41698-017-0024-z |
0.635 |
|
2017 |
Jose J, Tavares CDJ, Ebelt ND, Lodi A, Edupuganti R, Xie X, Devkota AK, Kaoud TS, Van Den Berg CL, Anslyn EV, Tiziani S, Bartholomeusz C, Dalby KN. Serotonin Analogues as Inhibitors of Breast Cancer Cell Growth. Acs Medicinal Chemistry Letters. 8: 1072-1076. PMID 29057053 DOI: 10.1021/Acsmedchemlett.7B00282 |
0.644 |
|
2017 |
Pandey R, Caflisch L, Lodi A, Brenner AJ, Tiziani S. Metabolomic signature of brain cancer. Molecular Carcinogenesis. PMID 28618012 DOI: 10.1002/Mc.22694 |
0.669 |
|
2017 |
Lu X, Solmonson A, Lodi A, Nowinski SM, Sentandreu E, Riley CL, Mills EM, Tiziani S. The early metabolomic response of adipose tissue during acute cold exposure in mice. Scientific Reports. 7: 3455. PMID 28615704 DOI: 10.1038/S41598-017-03108-X |
0.653 |
|
2017 |
Baran N, Han L, Sweeney SR, Lodi A, Herbrich S, Cavazos A, Ma H, Feng N, Chen H, Kaminski M, Dunner K, Tang G, Alatrash G, Molina J, Guzman ML, ... ... Tiziani S, et al. Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models Blood. 130: 1350-1350. DOI: 10.1182/Blood.V130.Suppl_1.1350.1350 |
0.648 |
|
2017 |
Quach DK, Harlow B, Winikka L, Brenner A, Beeram M, Tiziani S, Lengfelder L, Galvan G, Jolly C, deGraffenried L. Abstract 233: The impact of omega-3 fatty acid supplementation on obesity-induced inflammatory signaling within the breast tumor microenvironment Cancer Research. 77: 233-233. DOI: 10.1158/1538-7445.Am2017-233 |
0.303 |
|
2017 |
Saha A, Cramer SL, Kshattry S, Tiziani S, Stone E, Georgiou G, DiGiovanni J. Abstract 2132: Novel therapeutic approach through systemic depletion of L-cyst(e)ine with engineered cyst(e)inase enzyme for suppression of prostate tumor growth Cancer Research. 77: 2132-2132. DOI: 10.1158/1538-7445.Am2017-2132 |
0.37 |
|
2017 |
Kshattry S, Saha A, Cramer S, DiGiovanni J, Tiziani S, Munoz N, Georgiou G, Stone E. Abstract 105: Depletion of extracellular cystine and cysteine by a mutagenized human enzyme causes ROS mediated cytotoxicity in pancreatic cancer cells Cancer Research. 77: 105-105. DOI: 10.1158/1538-7445.Am2017-105 |
0.306 |
|
2017 |
Caflisch L, Lodi A, Gruslova A, Cavazos D, Garcia M, Tiziani S, Brenner A. METB-09. METABOLIC ADAPTATION TO CHRONIC HYPOXIA IN GLIOBLASTOMA CELLS Neuro-Oncology. 19: vi130-vi130. DOI: 10.1093/Neuonc/Nox168.533 |
0.661 |
|
2017 |
Gruslova A, Duque AD, Caflisch L, Tiziani S, Lodi A, Brenner A. DDIS-20. FASN INHIBITION AS A POTENTIAL TREATMENT TO PREVENT METABOLIC ADAPTATION IN GBM Neuro-Oncology. 19: vi63-vi63. DOI: 10.1093/Neuonc/Nox168.255 |
0.666 |
|
2017 |
Baran N, Lodi A, Sweeney S, Kuruvilla VM, Cavazos A, Velandy SS, Harutyunyan K, Feng N, Gay J, Kaminski M, Jabbour EJ, Ferrando A, Di Francesco ME, Tiziani S, Marszalek JR, et al. Targeting the Mitochondria Metabolism of T-ALL with Novel Mitochondrial Complex I Inhibitor IACS-010759 Clinical Lymphoma Myeloma and Leukemia. 17: S1-S2. DOI: 10.1016/J.Clml.2017.09.024 |
0.652 |
|
2017 |
Baran N, Han L, Herbrich S, Sweeney SR, Lodi A, Gay J, Feng N, Molina JR, Kaminski M, Guzman ML, Al-Atrash G, Tiziani S, Marszalek JR, Konopleva M. Novel Complex I inhibitor IACS-010759 Targets Leukemia Initiating Cells (LICs) in AML Patients Clinical Lymphoma Myeloma and Leukemia. 17: S297. DOI: 10.1016/J.Clml.2017.07.089 |
0.646 |
|
2017 |
Cai T, Lorenzi P, Rakheja D, Pontikos M, Lodi A, Han L, Zhang Q, Ma H, Rahmani M, Bhagat T, Horvath T, DiNardo C, Grant S, Tiziani S, Verma A, et al. GLS Inhibitor CB-839 Modulates Cellular Metabolism in AML and Potently Suppresses AML Cell Growth when Combined with 5-Azacitidine Clinical Lymphoma Myeloma and Leukemia. 17: S285-S286. DOI: 10.1016/J.Clml.2017.07.070 |
0.687 |
|
2016 |
Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, Triplett K, Lamb C, Alters SE, Rowlinson S, Zhang YJ, Keating MJ, Huang P, DiGiovanni J, Georgiou G, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nature Medicine. PMID 27869804 DOI: 10.1038/Nm.4232 |
0.348 |
|
2016 |
Matre P, Velez J, Jacamo R, Qi Y, Su X, Cai T, Chan SM, Lodi A, Sweeney SR, Ma H, Davis RE, Baran N, Haferlach T, Su X, Flores ER, ... ... Tiziani S, et al. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Oncotarget. PMID 27806325 DOI: 10.18632/Oncotarget.12944 |
0.698 |
|
2016 |
Sweeney SR, Kavanaugh A, Lodi A, Wang B, Boyle D, Tiziani S, Guma M. Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. Rmd Open. 2: e000289. PMID 27651926 DOI: 10.1136/Rmdopen-2016-000289 |
0.648 |
|
2016 |
Lashinger LM, O'Flanagan CH, Dunlap SM, Rasmussen AJ, Sweeney S, Guo JY, Lodi A, Tiziani S, White E, Hursting SD. Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors. Cancer & Metabolism. 4: 18. PMID 27651895 DOI: 10.1186/S40170-016-0158-4 |
0.666 |
|
2016 |
Guma M, Tiziani S, Firestein GS. Metabolomics in rheumatic diseases: desperately seeking biomarkers. Nature Reviews. Rheumatology. 12: 269-81. PMID 26935283 DOI: 10.1038/Nrrheum.2016.1 |
0.356 |
|
2016 |
Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, Boss GR, Tiziani S, Murphy AN, Guma M. Critical role of fibroblast-like synoviocytes glycolytic metabolism in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26815411 DOI: 10.1002/Art.39608 |
0.654 |
|
2016 |
Cai T, Lorenzi PL, Rakheja D, Pontikos MA, Lodi A, Han L, Zhang Q, Ma H, Rahmani M, Bhagat TD, Horvath TD, DiNardo CD, Grant S, Tiziani S, Verma A, et al. Gls Inhibitor CB-839 Modulates Cellular Metabolism in AML and Potently Suppresses AML Cell Growth When Combined with 5-Azacitidine Blood. 128: 4064-4064. DOI: 10.1182/Blood.V128.22.4064.4064 |
0.699 |
|
2016 |
Baran N, Molina J, Cavazos A, Harutyunyan K, Feng N, Gay J, Piya S, Shanmuga Velandy S, Jabbour EJ, Andreeff M, Tiziani S, Ferrando AA, Zweidler-McKay P, Di Francesco ME, Marszalek JR, et al. Mitochondrial Complex I Inhibition with Iacs-010759 in T-ALL Preclinical Models Blood. 128: 4028-4028. DOI: 10.1182/Blood.V128.22.4028.4028 |
0.405 |
|
2016 |
Sweeney SR, Sentandreu E, Tiziani S. Abstract 3: Amino acid profiles indicate dependence on different metabolic pathways between leukemia subtypes Cancer Research. 76: 3-3. DOI: 10.1158/1538-7445.Am2016-3 |
0.409 |
|
2016 |
Lu X, Wang B, Saha A, Sentandreu E, Lodi A, DiGiovanni J, Tiziani S. Abstract 12: Combinatorial intervention with natural compounds induces key metabolic modulations for prostate cancer prevention and treatment Cancer Research. 76: 12-12. DOI: 10.1158/1538-7445.Am2016-12 |
0.693 |
|
2015 |
Purać J, Kojić D, Popović ŽD, Vukašinović E, Tiziani S, Günther UL, Grubor-Lajšić G. Metabolomic Analysis of Diapausing and Noni-diapausing Larvae of the European Corn Borer Ostrinia nubilalis (Hbn.) (Lepidoptera: Crambidae). Acta Chimica Slovenica. 62: 761-7. PMID 26680702 DOI: 10.17344/Acsi.2015.1370 |
0.311 |
|
2015 |
Guma M, Sanchez-Lopez E, Lodi A, Garcia-Carbonell R, Tiziani S, Karin M, Lacal JC, Firestein GS. Choline kinase inhibition in rheumatoid arthritis. Annals of the Rheumatic Diseases. 74: 1399-407. PMID 25274633 DOI: 10.1136/Annrheumdis-2014-205696 |
0.649 |
|
2014 |
Kang Y, Tiziani S, Park G, Kaul M, Paternostro G. Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nature Communications. 5: 3672. PMID 24739485 DOI: 10.1038/Ncomms4672 |
0.325 |
|
2014 |
Matre P, Protopopova M, Feng N, Gay J, Greer J, Velez J, Mu H, Lodi A, Tadi S, Sweeney S, Andreeff M, Tiziani S, DiFrancesco ME, Marszalek J, Konopleva M. Novel Nanomolar Potency Mitochondrial Complex I Inhibitor Iacs-1131 Selectively Kills Oxphos-Dependent AML Cells Blood. 124: 622-622. DOI: 10.1182/Blood.V124.21.622.622 |
0.694 |
|
2014 |
Cavazos D, Gruslova A, Sun J, Floyd JR, Fichtel L, Tadi S, Lodi A, Tiziani S, Hart CP, Eng C, Brenner A. DD-02 * PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA Neuro-Oncology. 16: v60-v60. DOI: 10.1093/Neuonc/Nou246.2 |
0.639 |
|
2014 |
Brenner A, Floyd J, Eng C, Kroll S, Fichtel L, Gruslova A, Lodi A, Tiziani S. At-12Phase 1/2 Study Of Th-302, Investigational Hypoxia-Activated Prodrug, And Bevacizumab In Patients With Bevacizumab-Refractory Recurrent Glioblastoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou237.12 |
0.618 |
|
2013 |
Tiziani S, Kang Y, Harjanto R, Axelrod J, Piermarocchi C, Roberts W, Paternostro G. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia. Plos One. 8: e82859. PMID 24349380 DOI: 10.1371/Journal.Pone.0082859 |
0.404 |
|
2013 |
Lodi A, Tiziani S, Khanim FL, Günther UL, Viant MR, Morgan GJ, Bunce CM, Drayson MT. Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. Plos One. 8: e56422. PMID 23431376 DOI: 10.1371/Journal.Pone.0056422 |
0.646 |
|
2012 |
Ludwig C, Easton JM, Lodi A, Tiziani S, Manzoor SE, Southam AD, Byrne JJ, Bishop LM, He S, Arvanitis TN, Günther UL, Viant MR. Birmingham Metabolite Library: A publicly accessible database of 1-D 1H and 2-D 1H J-resolved NMR spectra of authentic metabolite standards (BML-NMR) Metabolomics. 8: 8-18. DOI: 10.1007/S11306-011-0347-7 |
0.632 |
|
2011 |
Tiziani S, Kang Y, Choi JS, Roberts W, Paternostro G. Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library. Nature Communications. 2: 545. PMID 22109519 DOI: 10.1038/Ncomms1562 |
0.388 |
|
2011 |
Lodi A, Tiziani S, Khanim FL, Drayson MT, Günther UL, Bunce CM, Viant MR. Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation. Acs Chemical Biology. 6: 169-75. PMID 20886892 DOI: 10.1021/Cb900300J |
0.705 |
|
2009 |
Romanska HM, Tiziani S, Howe RC, Günther UL, Gulzar Z, Lalani el-N. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts. Neoplasia (New York, N.Y.). 11: 1301-8. PMID 20019838 DOI: 10.1593/Neo.09850 |
0.398 |
|
2009 |
Khanim FL, Hayden RE, Birtwistle J, Lodi A, Tiziani S, Davies NJ, Ride JP, Viant MR, Gunther UL, Mountford JC, Schrewe H, Green RM, Murray JA, Drayson MT, Bunce CM. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. Plos One. 4: e8147. PMID 19997560 DOI: 10.1371/Journal.Pone.0008147 |
0.669 |
|
2009 |
Tiziani S, Lopes V, Günther UL. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia (New York, N.Y.). 11: 269-76, 4p following. PMID 19242608 DOI: 10.1593/Neo.81396 |
0.329 |
|
2009 |
Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Günther UL. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. Plos One. 4: e4251. PMID 19158949 DOI: 10.1371/Journal.Pone.0004251 |
0.688 |
|
2009 |
Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Günther UL. Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines Plos One. 4. DOI: 10.1371/Annotation/39584D38-04F5-4B37-Bfd8-Eae2318Ec6F9 |
0.624 |
|
2008 |
Tiziani S, Emwas AH, Lodi A, Ludwig C, Bunce CM, Viant MR, Günther UL. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Analytical Biochemistry. 377: 16-23. PMID 18312846 DOI: 10.1016/J.Ab.2008.01.037 |
0.636 |
|
2008 |
Tiziani S, Lodi A, Ludwig C, Parsons HM, Viant MR. Effects of the application of different window functions and projection methods on processing of 1H J-resolved nuclear magnetic resonance spectra for metabolomics. Analytica Chimica Acta. 610: 80-8. PMID 18267143 DOI: 10.1016/J.Aca.2008.01.030 |
0.611 |
|
2008 |
Tiziani S, Schwartz SJ, Vodovotz Y. Intermolecular interactions in phytochemical model systems studied by NMR diffusion measurements Food Chemistry. 107: 962-969. DOI: 10.1016/J.Foodchem.2007.08.089 |
0.577 |
|
2007 |
Lodi A, Tiziani S, Vodovotz Y. Molecular changes in soy and wheat breads during storage as probed by nuclear magnetic resonance (NMR). Journal of Agricultural and Food Chemistry. 55: 5850-7. PMID 17579434 DOI: 10.1021/Jf070636A |
0.715 |
|
2006 |
Tiziani S, Schwartz SJ, Vodovotz Y. Profiling of carotenoids in tomato juice by one- and two-dimensional NMR. Journal of Agricultural and Food Chemistry. 54: 6094-100. PMID 16881722 DOI: 10.1021/Jf061154M |
0.589 |
|
2005 |
Tiziani S, Vodovotz Y. Rheological characterization of a novel functional food: tomato juice with soy germ. Journal of Agricultural and Food Chemistry. 53: 7267-73. PMID 16131141 DOI: 10.1021/Jf0511087 |
0.566 |
|
2005 |
Tiziani S, Vodovotz Y. Rheological effects of soy protein addition to tomato juice Food Hydrocolloids. 19: 45-52. DOI: 10.1016/J.Foodhyd.2004.04.012 |
0.562 |
|
Show low-probability matches. |